CUF CEO Rui Diniz Flags an 'Accelerated' SNS Cost Curve in a Negócios-Antena 1 Interview — €17 Billion Annual Budget Now Crosses 90% of the €19.5 Billion IRS Take and Tests Long-Term Sustainability

Rui Diniz, chief executive of the private healthcare operator CUF, used a joint Jornal de Negócios and Antena 1 interview published on Saturday 23 May 2026 to flag what he called the "muito significativa" evolution of Serviço Nacional de Saúde (SNS) operating costs as a long-term sustainability concern the Portuguese debate is failing to confront. Diniz placed the SNS annual operating envelope at roughly €17 billion against an IRS revenue stream of roughly €19.5 billion — a ratio above 90% that he reads as a structural pressure on the country's fiscal capacity. The intervention arrives 48 hours after Prime Minister Luís Montenegro framed public-private partnerships as the SNS access backbone at the Hospital CUF Leiria inauguration, and is the first time a private-sector hospital CEO of his weight has put the cost-evolution number on the public record in such direct terms.

The 90% IRS Ratio Is the Number That Will Stick

The hardest line in the interview is the ratio Diniz framed between the SNS operating envelope and the IRS revenue stream. With the SNS at roughly €17 billion a year and IRS receipts at roughly €19.5 billion, the SNS now absorbs more than 90% of every euro the State collects through personal income tax. Diniz's reading is not that the SNS is too expensive in absolute terms — Portugal's per-capita health spend remains below the OECD average and below the EU-15 median — but that the cost trajectory over the recent years has been "de uma forma muito significativa" faster than the revenue trajectory underwriting it, and that the asymmetry compounds against the State's fiscal capacity at the margin.

The Diagnostic — Efficiency, Digitalisation, Less Costly Processes

The CEO's prescription is operational rather than fiscal. He called for "mais eficiência, mais digitalização, processos menos caros" — three levers that the private-sector hospital network has spent the past decade calibrating and that the SNS has historically struggled to deploy at scale. The digitalisation lever is the most concrete: SNS digital-prescription, electronic-health-record portability and tele-consultation coverage all sit measurably below the private-sector benchmark. The efficiency lever maps onto staffing-flexibility, theatre-utilisation and outpatient-pathway redesign — operational levers that the SNS regions have piloted across the 2020–2024 reform window with mixed results. The third lever — processos menos caros — points at procurement, at supply-chain consolidation and at the Compras-Públicas pipeline through which the SNS sources its medical-device and pharmacy envelope.

Management Capacity, Not Politics — the Frame Diniz Pushed

The CEO's most pointed line was the call for professional management expertise inside the SNS — a discipline he believes is undervalued in current discussions. The frame reads as a critique of the politicised cadence at the SNS executive level: directorate turnover that does not align with operational horizons, ministerial-level decisions that pre-empt regional-level management capacity and a chronic shortage of cross-sector executives who have worked both inside the SNS and inside the private hospital network. Diniz's own CV — built across the private-sector hospital chain — makes the management-track argument awkward to dismiss as ideologically motivated; the line is operationally framed even where the political subtext is unmistakable.

The Backdrop — PPPs, Hospital CUF Leiria and the Reform File

The intervention does not sit in isolation. The Government inaugurated Hospital CUF Leiria on Thursday 21 May with Health Minister Ana Paula Martins on the podium, and Montenegro used the moment to frame parcerias público-privadas as the SNS access backbone the legislature is preparing to legislate. The reform file is supposed to land before the end of the current parliamentary session, with a particular focus on the contractual frameworks that govern PPP hospitals (Hospital Beatriz Ângelo, Hospital de Cascais, Hospital de Loures, Hospital de Vila Franca de Xira) and the convenção architecture that determines how private operators absorb SNS-patient overflow. Diniz's interview is part of the public-record build-up to that reform, framed from the private-sector side of the negotiating table.

What This Means for Expats

If you are an SNS user (with a Cartão de Utente): the cost-curve question does not, in the near term, change the access entitlement you carry under the universal-coverage framework. What it does change is the political case that any government can make for capping or rationing the access in the medium term — a case that flows through to waiting lists, to specialty-access in the lower-funded SNS regions and to the prescription-formulary line. The political pressure point is the 2027 State Budget cycle.
If you carry private health insurance (an ADSE-style mutual or a commercial policy): Diniz's frame is the cleanest read on why the private-sector hospital network is positioning itself for an enlarged PPP role through the next reform cycle. The structural case for the private operator absorbing SNS overflow is partly a function of waiting-list dynamics, partly a function of capacity in the Lisbon-Porto axis and partly a function of the PPP contractual framework that the Government is preparing to legislate.
If you are an expat resident weighing whether to register under the SNS or to carry a private policy: the cost-curve debate is the macro frame on a question that ultimately falls to your usage pattern, your geographic location and your tolerance for the SNS waiting-list distribution. Within Lisbon and the Porto metropolitan area the private-sector capacity is dense enough that ADSE-equivalent coverage is the default professional-class posture; outside the two metropolitan areas the SNS-only posture remains the dominant cost-effective choice.
If you employ Portuguese staff with mandatory health-benefit obligations: the cost-curve line is the read on why the corporate health-insurance market has been expanding at roughly 6%–8% a year over the past three cycles. The benefit-design line will continue to migrate toward a hybrid posture — SNS as the base layer, private-policy top-up — as the cost-evolution debate shapes the political environment.

The intervention lands at the inflection point between the immediate PPP-reform legislation and the longer-horizon sustainability debate. Whether the 90%-of-IRS ratio reads as a structural alarm bell or as a contextual data point depends on the next round of OECD comparator-data the Direcção-Geral da Saúde publishes — and on whether the Ministério das Finanças accepts the Diniz frame at the upcoming Concertação Social table.